PlexBio Co., Ltd. Interviewed by FTV News Station

PlexBio Co., Ltd.


Taipei, Taiwan (June 29, 2017) – BioTaiwan 2017, Taiwan’s largest medical biotech exhibition took place June 28- July 2. The show featured the latest technologies and products including PlexBio’s patented πCode™ technology and the PlexBio™ 100 Analyzer for cancer-related gene mutations detection. PlexBio’s Chief Operating Officer, Dr. Stuart Palmer was interviewed by a news crew from FTV, interested in what the company’s products can do for healthcare and basic research. The PlexBio platform not only can be used in oncology and precision medicine, but it can also be applied in in a wide range of other fields, including infectious disease testing, immunological measurements and food testing among the other applications.


See full news report here: